Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 715 results for "erbitux"

BMS agrees to transfer Erbitux's North American business to Lilly
Pharma Letter

Bristol-Myers Squibb to transfer Erbitux North American rights...

Eli Lilly and Company and Bristol-Myers Squibb Company have collaborated to transfer rights to the cancer therapy, Erbitux, in North America, including the US, Canada, and Puerto Rico, from Bristol-Myers Squibb to Lilly. Rights include, but are not ... Individual.com, 3 days ago
[x]  

7 images for erbitux

Pharma Letter, 6 days ago
Pharma Letter, 2 months ago
Pharma Letter, 2 months ago
Pharma Letter, 2 months ago
Pharma Letter, 2 months ago
KXXV-TV, 4 months ago
KSWT13, 4 months ago
Creative Times

Competitor Analysis: EGF-R Antibodies 2015 - Biosuperiors and Biosimilars of Erbitux

(M2) Market Research Reports, Inc. has announced the addition of " " research report to their website http://www.MarketResearchReports.com
 Individual.com2 weeks ago Research and Markets: Competitor Analysis: EGF-R Antibodies 2015 - Biosuperiors and Biosimilars of Erbitux  Yahoo! UK and Ireland2 weeks ago RESEARCH AND MARKETS : Competitor Analysis: EGF-R Antibodies 2015 - Biosuperiors and Biosimilars of Erbitux  4 Traders2 weeks ago Research and Markets Offers Report: Competitor Analysis: EGF-R Antibodies 2015 [Professional Services Close - Up]  Pharmacy Choice1 week ago
[x]  

Merck to assume responsibility for promoting Erbitux in Japan

Merck has announced that it will take full responsibility for the promotion of Erbitux from Bristol-Myers in Japan, effective from May 1, 2015. "Expanding our oncology presence in Japan is of strategic importance to achieve our long term ambition to ...
 Individual.com2 months ago Merck gets full promotional responsibility for Erbitux in Japan  Pharmaceutical Business Review2 months ago Merck and Bristol-Myers Squibb to end co-promotion of Erbitux  Bionity.com2 months ago BRISTOL MYERS SQUIBB : Merck gets full promotional responsibility for Erbitux in Japan  4 Traders2 months ago

Bristol-Myers to Transfer Certain Erbitux Rights to Eli Lilly - Analyst Blog

Bristol-Myers Squibb Company BMY announced its intention to transfer its rights to the oncology drug, Erbitux, in North America, including the U.S., Canada, and Puerto Rico to Eli Lilly and Company LLY . The rights include full commercialization ...
 Zacks.com1 week ago

Merck takes back Japan Erbitux marketing rights, ending BMS arrangement

SINGAPORE--Merck KGaA said it has taken back Japan marketing rights for its best-selling Erbitux (cetuximab) cancer drug, ending its shared arrangement with Bristol-Myers Squibb ($BMY) effective May 1. The move was seen by the German Merck as ...
 Fierce Drug Delivery2 months ago Merck KGaA to Gain Full Marketing Rights to Erbitux in Japan - Analyst Blog  Zacks.com2 months ago Full-year sales in Merck KGaA's Serono unit lifted by fertility franchise, emerging markets  FirstWord Pharma1 month ago
[x]  

Eli Lilly (LLY) Snags North American Rights to Erbitux From Bristol-Myers Squibb (BMY) 4/16/2015

April 16, 2015 By Riley McDermid , BioSpace.com Breaking News Sr. Editor After a 14-year marriage, Bristol-Myers Squibb Company said Thursday that it will transfer the North American rights to cancer drug Erbitux (cetuximab) to partner Eli ...
 ClinicSpace1 week ago Eli Lilly Snags North American Rights to Erbitux From Bristol-Myers Squibb  BioSpace1 week ago

Forum Post: Chinese Lingzhi mushrooms as a supplement to Erbitux

my dad has larynx tumour and is going to be treated with Erbitux/Cetuximab +Radio. My sister and me we are very anxious about side effects of this treatment and we are thinking of different ways how it might be possible to support his body and make ...
 Macmillan Cancer Support1 month ago Forum Post: RE: Chinese Lingzhi mushrooms as a supplement to Erbitux  Macmillan Cancer Support1 month ago

New and Generic Drug Approvals: Erbitux

Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to
 U.S. Food and Drug Administration1 month ago

KaloBios Pharmaceuticals, Inc. (KBIO) Elects Ronald A. Martell To Board Of Directors

/PRNewswire/ -- KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced the election of veteran biopharmaceutical industry executive, Ronald A. Martell, to the KaloBios Board of Directors. "Ron is a seasoned biotechnology industry executive ...
 FierceBiotech2 days ago KaloBios Pharmaceuticals, Inc. Elects To Board Of Directors  BioSpace2 days ago KaloBios Elects Ronald A. Martell to Board of Directors  Fat Pitch Financials3 days ago KaloBios Pharmaceuticals : Elects Ronald A. Martell to Board of Directors  4 Traders3 days ago
[x]  

Eli Lilly (LLY) Q1 2015 Results - Earnings Call Transcript

Operator Welcome to the Q1 2015 Earnings Call. [Operator Instructions]. And I would now like to turn the conference over to your host, Chief Financial Officer, Mr. Derica Rice. Please go ahead, sir. Derica Rice Thank you. Good morning. And ...
 Seeking Alpha2 days ago Foamix's (FOMX) CEO Dr. Dov Tamarkin on Q4 2014 Results - Earnings Call Transcript  Seeking Alpha1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - erbitux
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less